Clinical trial
Comparison of Different Up-dosing Schedules With Osiris Phleum Pratense
NCT01425788 is registered in ClinicalTrials.gov with ALK-Abelló A/S as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Different Up-dosing Schedules With Osiris Phleum Pratense
- Lead sponsor
- ALK-Abelló A/S
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 2011
- Completion date
- February 29, 2012
- Enrollment
- 236 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rhino-conjunctivitis